SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome modelSheila Connelly, Michael Kaleko, Nur A. Hasan et al.|Journal of Applied Microbiology|2017Cited by 41
Clinical-Stage, Oral β-Lactamase Enzyme to Prevent Clostridium difficile Infection Triggered by Antibiotic-Mediated Gut Microbiome DisruptionSheila Connelly, Michael Kaleko, Andrew Bristol et al.|Open Forum Infectious Diseases|2016Cited by 0